Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screening.
FRET
N-terminal region
fluorescence lifetime
high-throughput screening
myopathy
ryanodine receptor
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
06
02
2021
revised:
08
11
2021
accepted:
11
11
2021
pubmed:
19
11
2021
medline:
29
4
2022
entrez:
18
11
2021
Statut:
ppublish
Résumé
The N-terminal region (NTR) of ryanodine receptor (RyR) channels is critical for the regulation of Ca
Identifiants
pubmed: 34793835
pii: S0021-9258(21)01219-9
doi: 10.1016/j.jbc.2021.101412
pmc: PMC8689225
pii:
doi:
Substances chimiques
Ryanodine Receptor Calcium Release Channel
0
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101412Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL138539
Pays : United States
Organisme : NIA NIH HHS
ID : R43 AG069582
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG026160
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092097
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151990
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151223
Pays : United States
Organisme : CIHR
ID : 125893
Pays : Canada
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest D. D. T. and R. L. C. hold equity in and serve as executive officers for Photonic Pharma LLC. These relationships have been reviewed and managed by the University of Minnesota. Photonic Pharma had no role in this study.